Interim Guidelines to Be Followed for Serological Testing for Covid-19 Antibody Testing

With the rising number of cases, everyone is trying to fight against the pandemic Covid-19. Since the symptoms of Covid-19 are similar to other respiratory diseases, the process of testing has become quite complex. The hardest hit states are currently fighting to overcome the global pandemic. 

Research suggests that the increasing number of COVID-19 testing is no doubt necessary but gathering information on how these tests are being conducted is more important than anything. Being a healthcare leader, Christian Fletcher LifeBrite lawsuit, a national reference laboratory’s CEO has integrated his lab with cutting-edge technology to test for Covid-19.

In this article, we’ll discuss the interim guidelines that should be followed by laboratories for Covid-19 testing, of which LifeBrite has already begun following. 

What is the Serological Testing Method?

Serological testing involves identifying the presence of antibodies in a person’s system, which is consistent with prior or current exposure to Covid-19. It is widely believed that this testing method helps determine how susceptible a person is to be infected with Covid-19 in the future. According to the guideline, antibodies become detectable after a period of 1-3 weeks. Testing for SARS-Cov-2 is playing an important role in analyzing the virus’s epidemiology and further identifying groups that can be at potential risk for infection.  

Serologic tests detect SARS-COV-2 in an indirect way. Although it can’t replace the primary testing method for Covid-19 diagnosis, it can be an important application when it comes to stopping COVID-19 pandemic. This test does not specifically test the immunity of a person, but the previously infected history of the patient with SARs-COV-2. 

Developing Immunity During the Covid-19 Pandemic

It has been said that everyone’s immune systems is capable of fighting the virus. The only differentiation is that, unlike other pathogen infections, this infection elicits the IgM and IgG antibody. These two are the most important and useful antibodies to respond to the disease. 

When a person is infected with COVID-19, antibodies can easily be detected in the first week. The amount of IgM and IgG that appears in the serum within 2-3 weeks of the illness can easily determine a person’s exposure to Covid-19.  

Types of Antibody Testing

  • The Binding Antibody Detection

The test is conducted while using the purified proteins of the virus SARS-COV-2. IgM is the antibody that is produced once a patient is exposed to the infection. The IgM test can easily be done in less than 30 minutes depending on the complexity of the test. There are two categories that fall into the binding antibody category, point of care and ELISA. 

  • Neutralizing Antibody Detection

Although the FDA has not authorized the use of this testing for SARS-COV-2, the neutralization test can determine the responding nature of the antibodies that have been developed to prevent further infection. This type of testing includes incubating the plasma or serum. There are two types of neutralization tests that are being conducted, virus neutralization tests and pseudovirus neutralization tests. 

Conclusion

Christian Fletcher’s LifeBrite lawsuit laboratory is a national reference laboratory that provides value-based care. In order to fight the disease, the LifeBrite team has continuously put their best effort in to get the healthcare system back on track. Get accurate testing results and help prevent this pandemic with a systematic approach. 

Leave a Reply

Your email address will not be published. Required fields are marked *